Adjuvant chemotherapy could improve the survival of pulmonary sarcomatoid carcinoma: A systematic review and meta-analysis

Complete surgical removal is currently considered to be the best treatment option for pulmonary sarcomatoid carcinoma (PSC) especially in early stage operable disease; however, the reported recurrence-free survival is low. Benefits of adjuvant chemotherapy in PSC patients are still controversial, an...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Surgical oncology 2022-09, Vol.44, p.101824-101824, Article 101824
Hauptverfasser:	Zombori-Tóth, Noémi, Kiss, Szabolcs, Oštarijaš, Eduard, Alizadeh, Hussain, Zombori, Tamás
Format:	Artikel
Sprache:	eng
Schlagworte:	Bias Chemotherapy Citation management software Clinical medicine Digital Object Identifier Immunotherapy Intervention Lung cancer Lung carcinoma Medical prognosis Meta-analysis Metastasis Mutation Patients Pulmonary sarcomatoid carcinoma Risk assessment Search strategies Surgery Survival Therapy Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!